BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

Ractigen Therapeutics' saRNA Drug RAG-01 Receives Fast Track Designation from FDA

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been g...

May 22, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

May 08, 2024 | News

Cytiva Innovates in Gene Therapy with Launch of ELEVECTA Cell Lines

Cytiva, a global leader in life sciences, has introduced its pioneering ELEVECTA cell lines, marking a significant advancement in...

May 07, 2024 | News

Takara Bio USA Introduces Innovative Lenti-X Transduction Sponge for Gene Delivery

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...

May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

MiLaboratories and Miltenyi Biotec Forge Partnership to Advance Next-Generation Therapies

MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership...

April 29, 2024 | News

Hyundai Bioscience Targets p53 Gene Mutations with Novel Niclosamide-Based Cancer Therapy

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatm...

April 26, 2024 | News

Thermo Fisher Scientific Establishes New Frontiers in Indonesia with Jakarta Office Opening and Strategic Partnerships

Thermo Fisher Scientific, the world leader in serving science, opens its inaugural office in Jakarta, Indonesia, marking a pivotal step in its strategic ex...

April 25, 2024 | News

Waters Corporation Launches Advanced GTxResolve™ Premier SEC Columns for Gene Therapy Development

New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene...

April 23, 2024 | News

Artiva Biotherapeutics Initiates First U.S. Trial of Allogeneic NK Cell Therapy for Lupus Nephritis

Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-bas...

April 18, 2024 | News

SCG Cell Therapy and A*STAR Launch Joint Labs to Advance Cellular Immunotherapy in Singapore

Collaboration aims to develop scalable GMP-grade iPSC manufacturing processes and therapeutic candidates to facilitate research leading to translation of...

April 18, 2024 | News

CSafe Launches Cryogenic Dewars for Cell and Gene Therapies

CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new l...

April 17, 2024 | News

IASO Bio's BCMA CAR-T Therapy Eque-cel Receives FDA Approval for U.S. Clinical Trials in Myasthenia Gravis

IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell ...

April 08, 2024 | News

YolTech Therapeutics Initiates Clinical Trial for Gene Editing Treatment YOLT-101 Targeting Familial Hypercholesterolemia

YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being develope...

April 03, 2024 | News

Stay Connected